Methyl N-(triethylammoniosulfonyl)carbamate → (S)-tert-butyl 4-(1-cyano-2-(4'-(isopropylsulfonyl)biphenyl-4-yl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate
Reaction equation
NC(=O)[C@@H](NC(C1(NC(=O)OC(C)(C)C)CCOCC1)=O)CC1C=CC(C2C=CC(F)=CC=2)=CC=1.[NH2:36][C:37](=O)[C@@H:38]([NH:58][C:59]([C:61]1([NH:67][C:68](=[O:74])[O:69][C:70]([CH3:73])([CH3:72])[CH3:71])[CH2:66][CH2:65][O:64][CH2:63][CH2:62]1)=[O:60])[CH2:39][C:40]1[CH:45]=[CH:44][C:43]([C:46]2[CH:51]=[CH:50][C:49]([S:52]([CH:55]([CH3:57])[CH3:56])(=[O:54])=[O:53])=[CH:48][CH:47]=2)=[CH:42][CH:41]=1.CC[N+](S(N=C(OC)[O-])(=O)=O)(CC)CC>ClCCl>[C:37]([C@@H:38]([NH:58][C:59]([C:61]1([NH:67][C:68](=[O:74])[O:69][C:70]([CH3:71])([CH3:73])[CH3:72])[CH2:66][CH2:65][O:64][CH2:63][CH2:62]1)=[O:60])[CH2:39][C:40]1[CH:45]=[CH:44][C:43]([C:46]2[CH:51]=[CH:50][C:49]([S:52]([CH:55]([CH3:57])[CH3:56])(=[O:54])=[O:53])=[CH:48][CH:47]=2)=[CH:42][CH:41]=1)#[N:36]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
The mixture of (S)-tert-butyl 4-(1-amino-3-(4′-fluorobiphenyl-4-yl)-1-oxopropan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate and (S)-tert-butyl 4-(1-amino-3-(4′-(isopropylsulfonyl)biphenyl-4-yl)-1-oxopropan-2-ylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (Example 4, step (i), 620 mg) in dichloromethane (15 mL) was treated with Burgess' reagent (462 mg) and the mixture was stirred at room temperature for 2 days. The reaction was absorbed onto silica and was purified by chromatography on silica eluting with 25% ethyl acetate in isohexane and then 50% ethyl acetate in isohexane to afford after evaporation of the relevant fractions (S)-tert-butyl 4-(1-cyano-2-(4′-fluorobiphenyl-4-yl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (218 mg) and (S)-tert-butyl 4-(1-cyano-2-(4′-(isopropylsulfonyl)biphenyl-4-yl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (300 mg).
Workup
- customThe reaction was absorbed onto silica
- customwas purified by chromatography on silica eluting with 25% ethyl acetate in isohexane
- custom50% ethyl acetate in isohexane to afford
- customafter evaporation of the relevant fractions (S)-tert-butyl 4-(1-cyano-2-(4′-fluorobiphenyl-4-yl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (218 mg) and (S)-tert-butyl 4-(1-cyano-2-(4′-(isopropylsulfonyl)biphenyl-4-yl)ethylcarbamoyl)tetrahydro-2H-pyran-4-ylcarbamate (300 mg)
Sources & evidence
- ORD record
- ord-cfcf682180584657b0a7b834e5fba82a
- Source dataset
- uspto-grants-2012_06
- Patent number
- US08193239B2
Reaction notes
Loading…